Last reviewed: June 27, 2026
Last updated: June 27, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide activates GLP-1 receptors in your brain and gut to reduce hunger signals and slow stomach emptying, but the timeline for visible weight loss varies by individual metabolism and starting dose. Understanding when to expect results helps you stay motivated during the early weeks of treatment. PlexusDx compounded semaglutide injection delivers the same active mechanism as branded versions at $149/month, making personalized GLP-1 therapy accessible without price barriers.
First Week: Initial Appetite Suppression on Semaglutide
Most patients report reduced hunger and increased fullness during meals within 3–7 days of starting semaglutide, even before significant weight loss occurs on the scale. This appetite suppression happens because semaglutide slows your gastric emptying rate and directly signals satiety centers in the hypothalamus. You may notice you feel satisfied with smaller portions and experience fewer cravings for high-calorie foods during this window.
Not all patients feel effects immediately; some take 10–14 days to notice behavioral changes around food. Individual variations depend on your baseline metabolism, liver function, and the specific genetic variants affecting your GLP-1 receptor sensitivity—factors the PlexusDx Precision Peptide Genetic Test can map to help predict your likely response timeline. Starting at a lower microdose can minimize nausea while allowing your system to acclimate.
Weeks Two to Four: When Weight Loss Becomes Measurable
Clinical trials show that measurable weight loss—typically 2–5 pounds—appears between days 10 and 28 for most patients following consistent semaglutide dosing. This timeline aligns with the drug reaching steady-state plasma concentrations in your bloodstream, which takes approximately one week at any given dose level. By week three, patients often report both tangible scale movement and noticeably looser clothing around the waist and midsection.
PlexusDx's starting dose of compounded semaglutide injection is calibrated to balance efficacy with tolerability during this critical window. If nausea or gastrointestinal side effects emerge during weeks two through four, your PlexusDx clinician can adjust your dose or timing, since your price remains flat at $149/month regardless of dose adjustments. Keeping a food and symptom journal during these first four weeks helps your provider optimize your protocol.
Month Two and Beyond: Accelerating Weight Loss and Metabolic Adaptation
After four weeks, weight loss velocity typically increases as your body adapts to the appetite-suppressing effects and your dose may be optimized upward if tolerated. Patients often experience 1–2 pounds of weight loss per week during months two through six, depending on adherence, dietary choices, and underlying metabolic rate. The compounded semaglutide formulation from licensed 503A pharmacies delivers consistent potency across this extended timeline.
Genetic variations in your FTO, MC4R, and GLP1R genes influence how quickly your metabolism responds to semaglutide's signaling, which is why some patients see faster progress than others at the same dose. PlexusDx's Precision Peptide Genetic Test identifies these variants, allowing your clinician to predict your likely response pattern and adjust timing or combination therapies (such as GLP-Squared) if needed. Your dose will almost certainly increase over months two through four, but your $149/month price for semaglutide injection remains unchanged.
Factors That Speed Up or Delay Semaglutide Weight Loss Results
Your individual timeline depends on starting body weight, baseline metabolic rate, insulin sensitivity, adherence to injection schedule, and nutritional choices between doses. Patients with higher baseline insulin resistance may see slower initial scale movement despite strong appetite suppression, because semaglutide also improves insulin secretion—a metabolic benefit that precedes visible weight loss. Consistent weekly injections, adequate protein intake, and moderate physical activity all accelerate your results window.
PlexusDx offers microdose GLP-1 protocols starting at $129/month for patients who want gentler initial activation, which can extend your timeline to visible results by 1–2 weeks but reduces nausea risk. If your genetic profile shows strong GIPR rs1800437 variants (mapped by the $99 Precision Peptide Genetic Test), dual-compound GLP-Squared may deliver faster results than semaglutide alone. All 50 states are served with no insurance requirement, making it easy to start, adjust, and personalize your therapy month-to-month.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I see weight loss results in the first week of semaglutide?
Scale weight loss within 7 days is uncommon, but appetite suppression and reduced food intake typically begin within days 3–7. Most measurable weight loss appears between weeks two and four as semaglutide reaches steady-state levels in your body. PlexusDx patients often report starting to feel different within days, even if the scale hasn't moved yet.
How much weight should I expect to lose per week on semaglutide?
Average weight loss is 1–2 pounds per week during months two through six, but some patients lose 0.5 pounds weekly and others lose 3+ pounds weekly depending on genetics, diet, and starting weight. Clinical trials show patients on semaglutide alone lose 10–15% of body weight over six months. PlexusDx's Precision Peptide Genetic Test can help predict your individual trajectory based on your GLP1R and FTO variants.
Why does PlexusDx compounded semaglutide cost only $149/month if my dose increases?
PlexusDx prices semaglutide injection at a flat $149/month across all dose levels, following the philosophy that your dose may need to go up but your price won't. This means you're never penalized for dose optimization—a major difference from per-dose or tiered pricing models that charge more for higher weekly amounts.
Is compounded semaglutide as effective as Ozempic or Wegovy?
PlexusDx compounded semaglutide from licensed 503A pharmacies contains the identical active ingredient and achieves the same metabolic effects as branded Ozempic and Wegovy. The main differences are cost, access (all 50 states, no insurance), and personalization options like the Precision Peptide Genetic Test. Efficacy timelines and weight loss expectations are equivalent.
What does the PlexusDx Precision Peptide Genetic Test show about my semaglutide timeline?
The $99 test identifies variants in GLP1R, GIPR, FTO, and MC4R genes that influence how your body responds to semaglutide's signaling and how quickly you'll enter steady appetite suppression. For example, certain GLP1R rs6923761 variants predict stronger initial response and faster weight loss velocity, while some FTO variants suggest gradual onset. This helps your clinician optimize starting dose and timeline expectations.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How Does Zepbound Compare to Wegovy?
Which Has Less Side Effects: Ozempic or Mounjaro?